Kronos Bio

$4.89 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Kronos Bio

Kronos Bio, Inc. operates as a biotechnology company. The Company discovers and develops therapies that modulate historically recalcitrant cancer targets. Kronos Bio serves customers in worldwide.

Stock Analysis

last close $4.89
1-mo return 13.2%
3-mo return 22.3%
avg daily vol. 254.63T
52-week high 25.01
52-week low 2.96
market cap. $315M
forward pe -
annual div. -
roe -46.1%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 67.1%
baraka

Subscribe now for daily local and international financial news

Subscribe